<DOC>
	<DOC>NCT02576951</DOC>
	<brief_summary>The purposes of this study are: - To evaluate tolerability of the LY2951742 solution injectable formulation (Part A) - To measure how much of the LY2951742 lyophilized (freeze dried) injectable formulation is absorbed into the blood stream and how long it takes the body to get rid of it compared to the LY2951742 solution injectable formulation after a single injection under the skin (subcutaneous [SC]) (Part B). Information about any side effects that may occur will also be collected. Each part of the study will last about six months. Participants may only enroll in one part.</brief_summary>
	<brief_title>A Study of LY2951742 in Healthy Participants</brief_title>
	<detailed_description />
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<criteria>Male and female healthy participants Have a body mass index of 19.0 to 35.0 kilograms per meter square (kg/mÂ²), inclusive Currently smoke in excess of 5 cigarettes/day</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>